Treatment of Myeloproliferative Neoplasms with Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety

被引：0
|
作者：
Long, Edouard [1 ]
Dunn, Roberta [1 ]
Li Gagnon, Laura [2 ]
Harrison, Claire [2 ]
Yang, Yunfan [2 ,3 ]
O'Sullivan, Jennifer [4 ]
机构：
[1] Kings Coll London, GKT Sch Med Educ, London, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England
[3] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China
[4] Guys & St ThomasNHS Fdn Trust, Dept Clin Haematol, London, England
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3168 / 3169
页数：2
相关论文
共 50 条
  • [1] Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety
    Dunn, Roberta
    Long, Edouard
    Gagnon, Laura Li
    Harrison, Claire
    Yang, Yunfan
    O'Sullivan, Jennifer
    EJHAEM, 2025, 6 (01):
  • [2] Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
    Rosenthal, Allison
    Mesa, Ruben A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1265 - 1276
  • [3] Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature
    Hunter, Anthony M.
    Bose, Prithviraj
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1391 - 1404
  • [4] The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
    Hobbs, Gabriela S.
    Rozelle, Sarah
    Mullally, Ann
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 613 - +
  • [5] Enhancing Quality of Life in Myeloproliferative Neoplasms: Insights from Janus Kinase Inhibitors-a Comprehensive Review and Meta-Analysis
    Shahzad, Moazzam
    Noor, Jawad
    Dave, Prashil
    Khalid, Muhammad Fareed
    Zaidi, Maheen
    Goyal, Shriya
    Naeem, Ammad
    Mir, Waleed Ahmed
    Anwar, Iqra
    Amin, Muhammad Kashif
    V. Jaglal, Michael
    Din, Mohammad Ammad Ud
    Mohammad, Turab
    Faisal, Muhammad Salman
    BLOOD, 2024, 144 : 6728 - 6728
  • [6] Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis
    Yang, Huibin
    An, Ting
    Zhao, Yuxuan
    Shi, Xiaojing
    Wang, Bangmao
    Zhang, Qingyu
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [7] Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
    Wei, Qige
    Wang, Hui
    Zhao, Jianglin
    Luo, Zhongping
    Wang, Chufeng
    Zhu, Chunmei
    Su, Na
    Zhang, Shengzhao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
    Li, Chenyang
    Sun, Xun
    Zhao, Kun
    Meng, Fanxiang
    Li, Lin
    Mu, Zhenzhen
    Han, Xiuping
    DERMATOLOGY, 2022, 238 (04) : 725 - 735
  • [9] Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (04) : 830 - 838
  • [10] Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
    Carlos Alves
    Ana Penedones
    Diogo Mendes
    Francisco Batel Marques
    International Journal of Clinical Pharmacy, 2023, 45 : 830 - 838
12345